Publication:
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis

dc.contributor.authorC. Heleen van Ommenen_US
dc.contributor.authorManuela Albisettien_US
dc.contributor.authorMohir Bhatten_US
dc.contributor.authorMarianne Bonduelen_US
dc.contributor.authorBrian Branchforden_US
dc.contributor.authorElizabeth Chalmersen_US
dc.contributor.authorAnthony Chanen_US
dc.contributor.authorNeil A. Goldenbergen_US
dc.contributor.authorSusanne Holzhaueren_US
dc.contributor.authorPaul Monagleen_US
dc.contributor.authorUlrike Nowak-Göttlen_US
dc.contributor.authorShoshana Revel-Vilken_US
dc.contributor.authorGabriela Sciuccatieen_US
dc.contributor.authorNongnuch Sirachainanen_US
dc.contributor.authorChristoph Maleen_US
dc.contributor.otherRoyal Hospital for Children, Glasgowen_US
dc.contributor.otherMcMaster Universityen_US
dc.contributor.otherUniversity of Colorado School of Medicineen_US
dc.contributor.otherUniversity of Melbourneen_US
dc.contributor.otherRoyal Children's Hospital, Melbourneen_US
dc.contributor.otherCharité – Universitätsmedizin Berlinen_US
dc.contributor.otherFaculty of Medicine Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherErasmus MC Sophia Children's Hospitalen_US
dc.contributor.otherMedizinische Universität Wienen_US
dc.contributor.otherHebrew University of Jerusalemen_US
dc.contributor.otherUniversitätsklinikum Schleswig-Holstein Campus Kielen_US
dc.contributor.otherKinderspital Zürichen_US
dc.contributor.otherAll Children's Hospital St. Petersburgen_US
dc.contributor.otherFundacion Hospital de Pediatria Professor Dr. Juan P. Garrahanen_US
dc.contributor.otherJohns Hopkins School of Medicineen_US
dc.date.accessioned2022-08-04T09:27:31Z
dc.date.available2022-08-04T09:27:31Z
dc.date.issued2021-04-01en_US
dc.description.abstractPediatric thromboembolism is a rare and heterogenous disease. As a result, there is a paucity of knowledge with regard to natural history, management, and outcomes of most types of pediatric venous and arterial thromboembolism. International research collaboration is needed to fill these knowledge gaps. Not only randomized controlled trials, but also representative observational studies are required to answer all research questions. Therefore, the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis initiated the International Pediatric Thrombosis Network (IPTN). The aims of the IPTN include (1) development of the Throm-PED registry to facilitate international prospective observational studies, and (2) establishment of a network of pediatric thrombosis centers experienced in effectively conducting clinical trials and observational studies. The IPTN needs dedicated clinicians all over the world and several funding sources to obtain high-quality research data to reach its ultimate goal of improving care in children with thrombosis. The aim of this communication is to call for active participation in the IPTN to all physicians taking care of children with thrombosis worldwide.en_US
dc.identifier.citationJournal of Thrombosis and Haemostasis. Vol.19, No.4 (2021), 1123-1129en_US
dc.identifier.doi10.1111/jth.15260en_US
dc.identifier.issn15387836en_US
dc.identifier.issn15387933en_US
dc.identifier.other2-s2.0-85103745080en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78307
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103745080&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleInternational pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103745080&origin=inwarden_US

Files

Collections